These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8531595)

  • 21. Lead increases lipopolysaccharide-induced liver-injury through tumor necrosis factor-alpha overexpression by monocytes/macrophages: role of protein kinase C and P42/44 mitogen-activated protein kinase.
    Cheng YJ; Yang BC; Liu MY
    Environ Health Perspect; 2006 Apr; 114(4):507-13. PubMed ID: 16581537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sinusoidal endothelial cell injury by superoxide anion and iron in the Propionibacterium acnes-pretreated and lipopolysaccharide-stimulated rat liver.
    Hasegawa T; Nakano M; Hashimoto T; Hiraishi K; Suzuki K; Kuwano H
    Liver; 2001 Dec; 21(6):415-24. PubMed ID: 11903887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rat liver macrophages express the 55 kDa tumor necrosis factor receptor: modulation by interferon-gamma, lipopolysaccharide and tumor necrosis factor-alpha.
    Zhang F; zur Hausen A; Hoffmann R; Grewe M; Decker K
    Biol Chem Hoppe Seyler; 1994 Apr; 375(4):249-54. PubMed ID: 8060533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endotoxin tolerance impairs a pertussis-toxin-sensitive G-protein regulating tumour necrosis factor release by macrophages from tumour-bearing rats.
    Altavilla D; Squadrito F; Canale P; Ioculano M; Campo GM; Squadrito G; Urna G; Sardella A; Caputi AP
    Pharmacol Res; 1996 Mar; 33(3):203-9. PubMed ID: 8880892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression, regulation, and production of tumor necrosis factor-alpha in mouse testicular interstitial macrophages in vitro.
    Xiong Y; Hales DB
    Endocrinology; 1993 Dec; 133(6):2568-73. PubMed ID: 8243279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventive effect of cyclosporin A on experimentally induced acute liver injury in rats.
    Wasaki S; Sakaida I; Uchida K; Kimura T; Kayano K; Okita K
    Liver; 1997 Apr; 17(2):107-14. PubMed ID: 9138282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The resistance of P. acnes--primed interferon gamma-deficient mice to low-dose lipopolysaccharide-induced acute liver injury.
    Shimizu Y; Margenthaler JA; Landeros K; Otomo N; Doherty G; Flye MW
    Hepatology; 2002 Apr; 35(4):805-14. PubMed ID: 11915026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids.
    Swierkosz TA; Mitchell JA; Warner TD; Botting RM; Vane JR
    Br J Pharmacol; 1995 Apr; 114(7):1335-42. PubMed ID: 7541688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Albendazole and colchicine modulate LPS-induced secretion of inflammatory mediators by liver macrophages.
    Viktorov AV; Yurkiv VA
    Bull Exp Biol Med; 2011 Oct; 151(6):683-5. PubMed ID: 22485207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of E3330, a novel quinone derivative, in galactosamine-induced hepatitis in rats.
    Nagakawa J; Hirota K; Hishinuma I; Miyamoto K; Sonoda J; Yamanaka T; Katayama K; Yamatsu I
    J Pharmacol Exp Ther; 1993 Jan; 264(1):496-500. PubMed ID: 8423547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-alpha.
    Wadsworth TL; McDonald TL; Koop DR
    Biochem Pharmacol; 2001 Oct; 62(7):963-74. PubMed ID: 11543732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative studies of cytotoxicity and the release of TNF-alpha, nitric oxide, and eicosanoids of liver macrophages treated with lipopolysaccharide and liposome-encapsulated MTP-PE.
    Dieter P; Ambs P; Fitzke E; Hidaka H; Hoffmann R; Schwende H
    J Immunol; 1995 Sep; 155(5):2595-604. PubMed ID: 7650390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effects of E3330, a novel quinone derivative, on galactosamine/tumor necrosis factor-alpha-induced hepatitis in mice.
    Nagakawa J; Hishinuma I; Hirota K; Miyamoto K; Yamanaka T; Yamatsu I; Katayama K
    Eur J Pharmacol; 1992 Dec; 229(1):63-7. PubMed ID: 1335420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1,25-Dihydroxyvitamin D3 inhibits thromboxane release from activated macrophages.
    Horiuchi H; Nagata I; Takahashi K; Tsuchimoto M; Komoriya K
    Res Commun Chem Pathol Pharmacol; 1992 Nov; 78(2):235-43. PubMed ID: 1475528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Products of lipopolysaccharide-activated macrophages (tumor necrosis factor-alpha, transforming growth factor-beta) but not lipopolysaccharide modify DNA synthesis by rat trophoblast cells exhibiting the 80-kDa lipopolysaccharide-binding protein.
    Hunt JS; Soares MJ; Lei MG; Smith RN; Wheaton D; Atherton RA; Morrison DC
    J Immunol; 1989 Sep; 143(5):1606-13. PubMed ID: 2474606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accelerated internalization and detoxification of endotoxin by anti-lipopolysaccharide antibody is an Fc receptor--mediated process.
    Lazaron V; Leslie DB; Wasiluk KR; Dunn DL
    Surgery; 2001 Aug; 130(2):192-7. PubMed ID: 11490348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of LPS-induced nitric oxide and TNF-alpha production by alpha-lipoic acid in rat Kupffer cells and in RAW 264.7 murine macrophages.
    Kiemer AK; Müller C; Vollmar AM
    Immunol Cell Biol; 2002 Dec; 80(6):550-7. PubMed ID: 12406389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of CD14 to endotoxin-induced liver injury may depend on types of macrophage activation in rats.
    Toshima K; Mochida S; Ishikawa K; Matsui A; Arai M; Ogata I; Fujiwara K
    Biochem Biophys Res Commun; 1998 May; 246(3):731-5. PubMed ID: 9618280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2.
    Heidenreich S; Gong JH; Schmidt A; Nain M; Gemsa D
    J Immunol; 1989 Aug; 143(4):1198-205. PubMed ID: 2473121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-activating factor antagonists suppress the generation of tumor necrosis factor-alpha and superoxide induced by lipopolysaccharide or phorbol ester in rat liver macrophages.
    Zhang F; Decker K
    Eur Cytokine Netw; 1994; 5(3):311-7. PubMed ID: 7948767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.